FDA issues draft guidance on CAM products
The FDA is announcing the availability of a draft guidance for industry entitled "Complementary and Alternative Medicine [CAM] Products and Their Regulation by the FDA." The draft guidance discusses when a CAM product is subject to the Federal Food, Drug, and Cosmetic Act or Public Health Service Act. Electronic comments may be submitted by April 30 to
Recent Videos
Related Content
Q&A: Retail, Independent Pharmacies Continue to Call for Improved Reimbursement Practices
June 30th 2025Article
Rick Gates, chief pharmacy officer at Walgreens and chairman of the National Association of Chain Drug Stores, discussed the current status of retail pharmacies and the way they are reimbursed.
